Alaunos Therapeutics (TCRT) EPS (Basic) (2009 - 2026)
Alaunos Therapeutics (TCRT) reported EPS (Basic) of -$0.59 for Q1 2026, up 11.94% on a YoY basis from -$0.53 in Q1 2025, and down 63.89% quarter-over-quarter from -$0.36 in Q4 2025.
Alaunos Therapeutics (TCRT) EPS (Basic) (2009 - 2026) Analysis & Trends
Alaunos Therapeutics has reported EPS (Basic) for 18 years, with the latest figure at -$0.59 in Q1 2026.
- For the quarter ending Q1 2026, EPS (Basic) rose 11.94% year-over-year to -$0.59; the trailing twelve-month figure through Mar 2026 stood at -$2.13 (up 16.14% YoY), and the FY2025 full-year result was -$2.2, up 24.66% from the prior year.
- EPS (Basic) for Q1 2026 stood at -$0.59, down from -$0.36 in the prior quarter.
- The five-year high for EPS (Basic) was -$0.04 in Q3 2022, with the low at -$5.49 in Q2 2023.
- Historically, EPS (Basic) has averaged -$1.45 across 5 years, with a median of -$0.63 in 2023.
- Annual changes were most pronounced in 2023 — EPS (Basic) sank 13150.0% — and 2024, when it jumped 90.61%.
- Alaunos Therapeutics' EPS (Basic) stood at -$2.48 in 2022, then plunged by 97.58% to -$4.9 in 2023, then jumped by 90.61% to -$0.46 in 2024, then rose by 21.74% to -$0.36 in 2025, then slumped by 63.89% to -$0.59 in 2026.
- The last three EPS (Basic) figures came in at -$0.59 (Q1 2026), -$0.36 (Q4 2025), and -$0.55 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -0.68 |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.06 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.00 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 0.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 0.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 4.06 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -0.06 |
| 10 | Alaunos Therapeutics | 4.31 Mn | 3.95 Mn | - | -0.59 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.59 |
| Dec 31, 2025 | -0.36 |
| Sep 30, 2025 | -0.55 |
| Jun 30, 2025 | -0.63 |
| Mar 31, 2025 | -0.67 |
| Dec 31, 2024 | -0.46 |
| Sep 30, 2024 | -0.70 |
| Jun 30, 2024 | -0.71 |
| Mar 31, 2024 | -1.05 |
| Dec 31, 2023 | -4.90 |
| Sep 30, 2023 | -5.30 |
| Jun 30, 2023 | -5.49 |
| Mar 31, 2023 | -0.63 |
| Dec 31, 2022 | -2.48 |
| Sep 30, 2022 | -0.04 |
| Jun 30, 2022 | -0.05 |
| Mar 31, 2022 | -0.05 |
| Dec 31, 2021 | -0.06 |
| Sep 30, 2021 | -0.11 |
| Jun 30, 2021 | -0.11 |